Top Industry News
- FDA puts company on notice for Marketing unapproved Stem Cell Products for Treating Serious Conditions
- FDA’s New Opioid Packaging Plan is Meant to Limit Overprescribing
- FDA Approves First NDA Under Real-Time Oncology Review Pilot
- EMA-EMA’s CHMP Offers Negative Opinion for Sickle Cell Drug Approved by US FDA
- FDA Should Reassess Postmarket Trials for Cancer Drugs Approved via Accelerated Pathway, Researchers Say